Yasmin Birth Control
June 4, 2011 by staff
Yasmin Birth Control, A security review of a popular pill among women in China is underway in the U.S. after reports that can cause blood clots than other products. Shanghai drug officials said they were following the progress of the review announced by the U.S. Food and Drug Administration, after two studies found a risk two to three times higher blood clots among women taking pills containing drospirenone, such as Bayer, Yaz, Yasmin, Beyaz, and Safyral.
Of the four, Yasmin is the only one sold in Mainland China. It has been available since 2009 and is produced in the German company’s plant in Guangzhou in south China’s Guangdong province.
U.S. FDA is evaluating the conflicting results of studies and will look at all information available to fully evaluate the risks and benefits of such pills. Continue to communicate any new safety information to the public as it becomes available, said in a statement.
European regulators have asked Bayer to edit information for prescription products to include new safety outcomes.
Du Wenmin, deputy director of Shanghai Center for Adverse Drug Reaction Monitoring clinic, said the center had received no reports of women suffering from blood clots after taking Yasmin.
He said that all birth control pills containing the female hormones, which can cause blood clots, especially for those with cardiovascular disease.
“The issue is whether the pill have an increased risk of blood clots, causing other birth control pills, and it will monitor the development of the event,” said Du. “For the sake of security, women with cardiovascular disease should take other measures of birth control pills instead.”
In a pharmacy Leiyunshang making Shanghai on Nanjing Road W. Yesterday, a package of pills Yasmin is on sale for 138 yuan (U.S. & 21). Other brands selling 30 yuan to 70 yuan.
“The pills are popular among women between 20 and 40, especially the white collar group,” said shop assistant Zhu Yilei. “Young women are likely to choose expensive pills and Yasmin as they believe that the more expensive, less side effects of pills that will bring in their health.”
“Although it appeared in our pharmacy since last December, its sales have been in line with other brands,” said Zhu, whose store sells about 50 packets of Yasmin each month.
Zhu added: “We have received no reports of adverse reactions in blood clots Yasmin to date and the venue has ordered us not to be especially aware of this pill.”
In a statement posted on its website, Bayer said the FDA review was the normal procedure to ensure the safety of the drug. The chances of blood clots were rare according to previous research.
Please feel free to send if you have any questions regarding this post , you can contact on
Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.